Amended Statement of Ownership: Solicitation (sc 14d9/a)
August 26 2016 - 6:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
14D-9
(Rule 14d-101)
Solicitation/Recommendation Statement
Under Section 14(d)(4) of the Securities Exchange Act of 1934
(Amendment No. 4)
SEQUENOM,
INC.
(Name of Subject Company)
SEQUENOM,
INC.
(Name of Person Filing Statement)
Common Stock,
$0.001 par value per share
(Title of Class of Securities)
817337405
(CUSIP Number
of Class of Securities)
Dirk van den Boom, Ph.D.
President, Chief Executive Officer and Director
3595 John Hopkins Court
San Diego, California 92121
(858) 202-9000
(Name,
Address and Telephone Number of Person Authorized to Receive Notices and Communications
on Behalf of the Person Filing Statement)
With copies to:
L. Kay Chandler, Esq.
Rama Padmanabhan, Esq.
Barbara L. Borden, Esq.
Cooley LLP
4401 Eastgate
Mall
San Diego, CA 92121
(858) 550-6000
¨
|
|
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
|
This Amendment No. 4 (this Amendment) to Schedule 14D-9 amends and supplements the
Solicitation/Recommendation Statement on Schedule 14D-9 (as amended or supplemented from time to time, the Schedule 14D-9) previously filed by Sequenom, Inc., a Delaware corporation (Sequenom), with the Securities and
Exchange Commission on August 9, 2016, relating to the offer by Laboratory Corporation of America Holdings, a Delaware corporation (Parent) and Savoy Acquisition Corp., a Delaware corporation and a direct wholly owned subsidiary of
Parent (Purchaser), to purchase all of the issued and outstanding shares of Sequenom common stock, including the associated preferred stock purchase rights issued under the Rights Agreement, dated March 3, 2009, as amended, between
Sequenom and American Stock Transfer & Trust Company (such stock and associated rights, the Shares), for $2.40 per Share, in cash, without interest and less any applicable withholding taxes or other taxes, upon the terms and subject
to the conditions set forth in the Offer to Purchase, dated August 9, 2016, and in the related Letter of Transmittal, each of which may be amended or supplemented from time to time.
Except as otherwise set forth below, the information set forth in the Schedule 14D-9 remains unchanged and is incorporated by reference as
relevant to the items in this Amendment. Capitalized terms used and not defined herein shall have the meanings assigned to such terms in the Schedule 14D-9. This Amendment is being filed to reflect certain updates as reflected below.
Item 9
of the Schedule 14D-9 is hereby amended and supplemented by adding the following hereto:
|
|
|
Exhibit
Number
|
|
Description
|
|
|
(a)(7)
|
|
Employee Q&A emailed to the Companys employees and posted to the Companys internal website on August 25, 2016.
|
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and
correct.
|
|
|
SEQUENOM, INC.
|
|
|
By:
|
|
/s/ Jeffrey D. Linton
|
Name:
|
|
Jeffrey D. Linton
|
Title:
|
|
Senior Vice President, General Counsel and Secretary
|
Dated: August 26, 2016
Sequenom, Inc. (NASDAQ:SQNM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sequenom, Inc. (NASDAQ:SQNM)
Historical Stock Chart
From Jul 2023 to Jul 2024